Iron Triangle Partners LP - Q2 2021 holdings

$971 Million is the total value of Iron Triangle Partners LP's 26 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 100.0% .

 Value Shares↓ Weighting
RPRX ExitROYALTY PHARMA PLC$0-100,000
-100.0%
-0.56%
OM ExitOUTSET MED INC$0-100,000
-100.0%
-0.69%
VCEL ExitVERICEL CORP$0-160,000
-100.0%
-1.13%
EXAS ExitEXACT SCIENCES CORP$0-100,000
-100.0%
-1.68%
NTRA ExitNATERA INC$0-150,000
-100.0%
-1.94%
IQV ExitIQVIA HLDGS INC$0-100,000
-100.0%
-2.46%
SGRY ExitSURGERY PARTNERS INC$0-725,000
-100.0%
-4.08%
HAE ExitHAEMONETICS CORP MASS$0-330,000
-100.0%
-4.66%
LH ExitLABORATORY CORP AMER HLDGS$0-170,000
-100.0%
-5.51%
UNH ExitUNITEDHEALTH GROUP INC$0-160,000
-100.0%
-7.57%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HORIZON THERAPEUTICS PUB LTD12Q3 20229.0%
GUARDANT HEALTH INC12Q3 20226.1%
CHARLES RIV LABS INTL INC11Q1 20237.8%
SURGERY PARTNERS INC11Q2 20236.4%
ICON PLC10Q3 202311.7%
BOSTON SCIENTIFIC CORP10Q3 20238.9%
NEVRO CORP10Q1 20226.7%
DEXCOM INC10Q3 20237.7%
ABBVIE INC9Q3 20238.1%
ACADIA HEALTHCARE COMPANY IN9Q3 20237.9%

View Iron Triangle Partners LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Iron Triangle Partners LP's complete filings history.

Compare quarters

Export Iron Triangle Partners LP's holdings